Visit us at ISBT 2022 Virtual Congress

We are looking forward to virtually interacting with you at the ISBT 2022 Virtual Congress. Please take a moment to visit the Grifols Exhibitor Page where you can learn more about the solutions and services we offer to help you work efficiently to deliver safe and compatible blood for patients.

The virtual congress will open from June 4 to June 8, 2022. To get updates on our products, services, as well as scientific and educational opportunities, you can join us by signing up.

 

 

Products Highlighted at ISBT 2022

Grifols is a recognized leader in transfusion medicine with a comprehensive portfolio of products designed to support safety from donation through transfusion.

 

Donor Screening

Our Procleix NAT solutions deliver high-quality, fully automated and integrated blood screening to your laboratories – from community blood centers to consolidated testing facilities around the world. Procleix platforms screen more donors globally than any other NAT blood screening solution1.
 
The Procleix Panther system expands your laboratory's capabilities to anticipate the blood screening needs of today and tomorrow with a continuously growing assay menu.
 

Procleix Plasmodium assay receives CE mark! – New!

The nucleic acid test (NAT) detects the presence of Plasmodium species in blood donors, preventing the risk of transfusion-transmitted infections by this parasite responsible for over 240 million infections and 620,000 deaths globally.2
 
The Procleix Plasmodium Assay uses Transcription-Mediated Amplification (TMA) to detect the presence of ribosomal RNA of five species of Plasmodium parasites (P. falciparum, P. knowlesi, P. malariae, P. ovale, and P. vivax) in whole blood samples.
 
This assay will help prevent infected blood from being transfused even when the donor does not exhibit symptoms and traditional screening techniques are not able to detect the presence of the pathogen against it.
 

Procleix UltrioPlex E Assay

One makes the difference
 
Unique NAT assay that detects HEV, HIV-1, HIV-2, HCV, and HBV for donor screening preventing the risk of transfusion transmitted infections. All five viruses are detected in just one test.
 
The UPxE Assay will provide blood banks and blood testing institutions with a streamlined workflow for the detection of leading causes of transfusion transmitted infection.
 
The comprehensive multiplex detection capability of this assay provides added benefits such as efficient use of laboratory space, reduction of environmental impact, simple reagents management, and improved workflow and operations.
 

Procleix Panther system featuring ART (Panther ART)

Innovation that empowers innovation
 
The Panther ART is designed to allow donor screening labs to optimize variable workflow needs by offering superior customization with easy, scalable options that help transform the way you work as your lab needs evolve. Panther ART retains key Panther features as continuous loading and release of results, 24-hr calibration, no end-controls, and up to 4 assays of the same sample.
 
Panther ART offers multiple options that provides the flexibility to laboratories in planning and implementing next-level screening automation:
 
  • On-demand access when you need it
  • Remote dashboard
  • Data sharing MTU expansion module
  • Direct-to-drain waste management
  • Sample shuttle module
 
Reduce sample touch points via a track system that allows samples to travel in and out of the Panther ART without operator's intervention.
 

1. Source: Grifols, data on file, June 2019.

2. Source: World Malaria Report 2021, WHO.

Procleix Panther system featuring ART
Procleix Assays

Blood Typing

Grifols blood typing solutions portfolio provides the primary needs of immunohematology laboratories, offering techniques for each testing need and laboratory workflow, and the expert support of a specialized global partner.
 
Since no two immunohematology laboratories are identical, Grifols offers a wide range of instruments that are specifically tailored to suit different processing needs. Choose the system that best fits your laboratory needs, whether it's fully automated, semi-automated, or manual processing. 
 
The Erytra, Erytra Eflexis, and DG Reader Net are true scalable systems that offer different throughput and capacities, while using the same reagents and sharing the equivalent software suite.
 
Learn more about our scalable solutions by attending one of our product presentations during each day of the congress.
 

Erytra

Fully automated, high-throughput, high-capacity instrument that performs pretransfusion compatibility tests using DG Gel technology. Erytra combines efficiency and flexibility with intuitive operation that adapts to laboratory needs.

 

Erytra Eflexis

Fully automated, mid-size analyzer that performs pretransfusion compatibility tests using DG Gel technology. This highly efficient instrument helps labs achieve workflow efficiency by providing continuous access to the instrument, samples, and reagents.
 
 

DG Reader Net

Desktop, automated instrument for reading and interpreting DG Gel cards. Advance to an automated experience for manual gel testing by combining the scalability, flexibility, and intuitive operations of this device.

 

Erytra Automated System for Blood Typing
Erytra Eflexis Automated System for Blood Typing
DG Reader Net system

Support & Services

Diagnostic Support & Services provides solutions that facilitate high quality patient care and let lab professionals focus on their patients. Our mission is to help you deliver reliable results on time, anticipate lab needs, and provide peace of mind.
 
From installation and setup to on-site service and training, we offer solutions for every need.
 

This information is intended for physicians and healthcare professionals only.

Product registration and availability vary by country. For more information on product availability, please contact us here.